G. Scalise

发表

CTBP 1 and metabolic syndrome induce an mRNA and miRNA expression profile critical for breast cancer progression and metastasis

K. Gardner, A. Siervi, P. D. Luca, 2018 .

CtBP1 associates metabolic syndrome and breast carcinogenesis targeting multiple miRNAs

K. Gardner, A. De Siervi, P. De Luca, 2016, Oncotarget.

CTBP1 depletion on prostate tumors deregulates miRNA/mRNA expression and impairs cancer progression in metabolic syndrome mice

A. De Siervi, P. De Luca, G. Gueron, 2019, Cell Death & Disease.

CTBP1 depletion on prostate tumors deregulates miRNA/mRNA expression and impairs cancer progression in metabolic syndrome mice

K. Gardner, A. De Siervi, P. De Luca, 2019, Cell Death and Disease.

CTBP1/CYP19A1/estradiol axis together with adipose tissue impacts over prostate cancer growth associated to metabolic syndrome

K. Gardner, A. De Siervi, P. De Luca, 2018, International journal of cancer.

CLCA2 epigenetic regulation by CTBP1, HDACs, ZEB1, EP300 and miR‐196b‐5p impacts prostate cancer cell adhesion and EMT in metabolic syndrome disease

K. Gardner, A. De Siervi, P. De Luca, 2018, International journal of cancer.

Adipose tissue from metabolic syndrome mice induces an aberrant miRNA signature highly relevant in prostate cancer development

K. Gardner, A. De Siervi, E. Lacunza, 2020, Molecular oncology.

CTBP1 and metabolic syndrome induce an mRNA and miRNA expression profile critical for breast cancer progression and metastasis

K. Gardner, A. De Siervi, P. De Luca, 2018, Oncotarget.

miR-877-5p as a Potential Link between Triple-Negative Breast Cancer Development and Metabolic Syndrome

A. De Siervi, E. Lacunza, P. L. Farré, 2023, International journal of molecular sciences.